As STING activation is crucial for anti-cancer immune response [18], and we previously found that metformin enhanced the efficacy of immunotherapy in STK11 mutant lung cancer via AXIN1-based STING stabilization [16], whether the nucleotide compounds involved in the activation of STING were unknown. The gene discussed is AXIN1; the disease is lung carcinoma.